Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
national blog main
san francisco blog main
7
×
biotech
boston blog main
boston top stories
clinical trials
new york blog main
new york top stories
san francisco top stories
eli lilly
fda
national
national top stories
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
bristol-myers squibb
cancer drugs
chronic kidney disease
europe blog main
fremanezumab
immunotherapy
investing
What
companies
7
×
new
7
×
drug
ipo
life
medicines
approval
bio
biotech
cancer
hasn’t
latest
momentum
raised
research
science
sciences
therapeutics
week
arguments
arrival
bets
better
big
biogen’s
biopharmaceutical
biotechs
black
california
class
clinic
clinicians
club
comes
commercialized
community
competitors
continued
convo
crop
Language
unset
Current search:
companies
×
" san francisco blog main "
×
new
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
California Life Sciences Fueled by Education, Established Companies
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines